Literature DB >> 3592564

Analysis of morphine and its major metabolites by differential radioimmunoassay.

C W Hand, R A Moore, H J McQuay, M C Allen, J W Sear.   

Abstract

The analysis of morphine, morphine-3-glucuronide (M-3-G) morphine-6-glucuronide (M-6-G) by differential radioimmunoassay using iodinated label and three different antisera is described. These methods were used to measure concentrations of morphine and its conjugated metabolites in human plasma, over a 3-h period, following a single 10 mg intravenous dose. In 13 patients peak concentrations of M-3-G (739 nmol/L +/- 73.7 SEM) were approximately 10 times greater than those of M-6-G (71.3 nmol/L +/- 8.6 SEM). Times to reach these peaks were similar for both metabolites. Decay of morphine from plasma followed a biexponential pattern with a mean terminal half-life of 59.3 min (+/- 8.1 SEM, n = 11). Accurate determination of the half-lives of the glucuronides was not possible due to the short sampling period, but M-6-G seemed to have a similar half-life to morphine, while M-3-G was eliminated more slowly.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592564     DOI: 10.1177/000456328702400205

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  7 in total

1.  Absence of morphine glucuronidation in the human lung.

Authors:  F M Ratcliffe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

Authors:  P J Hoskin; G W Hanks; G W Aherne; D Chapman; P Littleton; J Filshie
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

3.  Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2018-02-06       Impact factor: 3.739

4.  [Oral papaverine prevents morphine-induced constipation without interfering with analgesia achieved with oral morphine].

Authors:  I Jurna; K Jurna; J Baldauf; M Zenz
Journal:  Schmerz       Date:  1996-02-15       Impact factor: 1.107

Review 5.  Morphine-3-Glucuronide, Physiology and Behavior.

Authors:  Florian Gabel; Volodya Hovhannisyan; Abdel-Karim Berkati; Yannick Goumon
Journal:  Front Mol Neurosci       Date:  2022-05-12       Impact factor: 6.261

6.  Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.

Authors:  O Dale; J Thoner; T Nilsen; T Tveita; P C Borchgrevink; P Klepstad
Journal:  Eur J Clin Pharmacol       Date:  2007-07-10       Impact factor: 2.953

Review 7.  Inter-individual variation in morphine clearance in children.

Authors:  Mohammed I Altamimi; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2015-04-08       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.